LDS/Medical Tests/The NeuroPointDX Autism Spectrum Disorder (NPDX ASD) Blood Test

The NeuroPointDX Autism Spectrum Disorder (NPDX ASD) Blood Test

Autism spectrum disorder (ASD) is highly heritable, heterogeneous, and among the most prevalent neurodevelopmental disorders, affecting ~2% of U.S. children. Clinical features include challenges in social communication and interaction, restricted interests, repetitive behaviors, and attention difficulties. Diagnosis has traditionally relied on behavioral assessments, but biological tools are emerging to complement clinical evaluation.

The NeuroPointDX ASD Blood Test analyzes specific biomarkers that serve as molecular signatures associated with ASD. The test includes two metabolomic panels:1) Amine Panel: 32 amino acid and amine metabolites, and 2) Energy Panel: 16 metabolites reflecting mitochondrial, microbiome, and energy metabolism.

These results are compared against validated ASD-associated metabolic profiles from the Children’s Autism Metabolome Project (CAMP), involving over 1,100 children. A proprietary algorithm classifies ASD-associated metabotypes and provides a positive/negative overall result with interpretation of metabolic imbalances. The test is non-invasive and offers potential for earlier detection of ASD, though it is not a standalone diagnostic and requires comprehensive clinical evaluations.

  • Early diagnosis and monitoring of autism spectrum disorders
  • Provides metabolic insights to guide individualized care, interventions, and therapy planning

Positive Result:

  • Indicates a metabolic imbalance consistent with ASD-associated metabotypes, suggesting higher likelihood of ASD and supports referral for early intervention and specialist evaluation

Negative Result:

  • Does not rule out ASD, as ~28% of ASD cases may not be detected by this test.

Reported as Positive or Negative relative to algorithm-defined thresholds

Mass spectrometry-based metabolomic panels interpreted using proprietary algorithms validated against CAMP study data.

Whole blood, EDTA.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 20 days
Autoimmune brain panel (Cunningham panel,) chromosomal microarray, folic acid, MTHFR gene mutation analysis, lead, vitamin B12, Vitamin D, FMR1 gene mutation analysis.
3 to 5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login